BioNTech: The three principal shareholders, CEO Ugur Sahin & Germany’s Strüngmann twins, Andreas & Thomas, who provided much of the initial se

BioNTech: The three principal shareholders, CEO Ugur Sahin & Germany’s Strüngmann twins, Andreas & Thomas, who provided much of the initial se